Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/2003
06/11/2003EP1317283A2 Tweak receptor agonists as anti-angiogenic agents
06/11/2003EP1317282A2 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS
06/11/2003EP1317280A2 Vaccine against streptococcus pneumoniae
06/11/2003EP1317279A2 Vaccine against streptococcus pneumoniae
06/11/2003EP1317278A2 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom
06/11/2003EP1317273A1 Use of il-6r/il-6 chimera in huntington's disease
06/11/2003EP1126874B1 Multicomponent meningococcal vaccine
06/11/2003EP0662086B1 Protein l and hybrid proteins thereof
06/11/2003EP0661997B1 Method of increasing egg production in avian species by active immunization against vasoactive intestinal peptide
06/11/2003EP0644900B1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and its use
06/11/2003EP0638119B1 Chimeric receptor genes and cells transformed therewith
06/11/2003EP0539492B1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins
06/11/2003CN1423700A Multifunctional polypeptides comprising a binding site to and epitope of the NKG2D receptor complex
06/11/2003CN1423698A The Genome of the HIV-1 inter-subtype (C/B') and use thereof
06/11/2003CN1423697A Virulence genes and proteins and their use
06/11/2003CN1423693A Method for the production of vitamin A
06/11/2003CN1423660A Antibodies
06/11/2003CN1423659A Recombinant gelatins
06/11/2003CN1423657A Inter feron-alpha induced gene
06/11/2003CN1423563A Pancreatic stem cells and their use in transplantation
06/11/2003CN1422950A Recombinant gland-related virus expressing human blood angiotonin II receptor I antisense gene and preparation method thereof
06/11/2003CN1422888A Nucleic compound and production method thereof, and its use in the preparation of immune formulation
06/11/2003CN1422869A Diphtherin-gonadoliberin chimeric protein
06/11/2003CN1422864A Zinc finger protein and its antibody preparation and use
06/11/2003CN1111071C Vaccines containing saponin and sterol
06/10/2003US6576793 β2-adrenergic receptor agonists
06/10/2003US6576758 Nucleic acid constructs containing hybrid promoters
06/10/2003US6576757 Polynucleotides encoding flavivirus and alphavirus multivalent antigenic polypeptides
06/10/2003US6576756 Nucleotide sequences coding polypetide for use in the diagnosis and treatment of cancer
06/10/2003US6576751 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
06/10/2003US6576750 Isolated cDNA or RNA molecule that encodes a protein of given amino acid sequence; cDNA or RNA comprising a nucleotide sequence; can use for vaccines and chemotherapeutic drugs
06/10/2003US6576467 Methods for producing recombined antibodies
06/10/2003US6576466 Activation; separation
06/10/2003US6576437 Stimulus-inducible protein kinase complex and methods of use therefor
06/10/2003US6576434 Transport protein of given amino acid sequence; exposing cells that express the protein to compound; measuring ion transport; use in treatment of interleukin mediated atopic allergy, asthma and cystic fibrosis
06/10/2003US6576431 Treatment for myocardial infarction; enhancing clot lysis
06/10/2003US6576417 Synthetic antigens for the detection of antibodies to hepatitis C virus
06/10/2003US6576244 LT and CT in parenteral immunization methods against helicobacter infection
06/10/2003US6576243 Polynucleotide vaccine formula against porcine reproductive and respiratory pathologies
06/10/2003US6576240 Antigenic structural peptide, antigenic and immunogenic compounds, and uses for detecting, preventing and treating an HCV infection
06/10/2003US6576238 Isolated protein selected from protein having specified amino acid sequence, or protein comprising homologue of flea protein comprising portion of specified amino acid sequence, which elicits antibody response against flea protein
06/10/2003US6576236 Contacting T cell which expresses cytokine receptor gamma chain with anti-gamma chain antibody which binds to and transduces signal via gamma chain such that T cell responsiveness is stimulated
06/10/2003CA2234208C Influenza vaccine
06/10/2003CA2166367C Live recombinant avian vaccine using an avian herpesvirus as vector
06/10/2003CA2143416C Inhibitor of collagen-stimulated platelet aggregation
06/10/2003CA2121121C Preparation of recombinant borrelia proteins
06/10/2003CA2107340C Monoclonal antibodies against human tnf-binding protein i (tnf-bp i)
06/07/2003CA2376719A1 A method to improve the safety of gene therapy
06/05/2003WO2003046581A2 Methods for diagnosis and treatment of epithelial-derived cancers,such as colorectal cancers and kidney cancers
06/05/2003WO2003046560A2 Self-assembly molecules
06/05/2003WO2003046506A2 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies
06/05/2003WO2003046204A2 Humanized collagen antibodies and related methods
06/05/2003WO2003046189A1 Flavivirus vaccine delivery system
06/05/2003WO2003046179A2 G-protein coupled receptor lustr2 and uses thereof
06/05/2003WO2003046171A1 A method for combined sequential agent delivery and electroporation for cell structures and use thereof
06/05/2003WO2003046170A1 A method for combined parallel agent delivery and electroporation for cell structures and use thereof
06/05/2003WO2003046137A2 Hiv envelope v3-ccr5 binding site immunogen
06/05/2003WO2003046135A2 Osteopontin-related compositions and methods
06/05/2003WO2003046124A2 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
06/05/2003WO2003046012A1 Antigen presenting cell targeting conjugate, an antigen presenting cell contacted with such conjugate, their use for vaccination or as medicament, and methods for their production or generation
06/05/2003WO2003046011A1 Antigen presenting cell targeting conjugate an antigen presenting cell contacted with such conjugate their use for vaccination or as medicament and methods for their production or generation
06/05/2003WO2003046008A1 Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma
06/05/2003WO2003046007A2 Treatment of micro-organism infection
06/05/2003WO2003045997A2 Fusion proteins containing tlp peptides
06/05/2003WO2003045984A2 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance
06/05/2003WO2003045978A2 Antagonist anti-cd40 monoclonal antibody therapy for multiple sclerosis treatment
06/05/2003WO2003045466A2 Catheter composition and uses thereof
06/05/2003WO2003045431A2 Methods for treating cancer using a combination of a tumor-derived dendritic cell inhibitory factor antagonist and a toll-like receptor agonist
06/05/2003WO2003045429A2 Anti-t cell immunotoxin fusion protein and its therapeutic use
06/05/2003WO2003045428A2 Use of a technically modified cell as a vaccine for treating tumoral disease
06/05/2003WO2003045427A2 Pharmaceutical composition for inducing an immune response in a human or animal
06/05/2003WO2003045426A1 T-cell epitodes in carboxypeptidase g2
06/05/2003WO2003045420A2 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization
06/05/2003WO2003045412A1 Mint extract and related pharmaceutical compositions
06/05/2003WO2003045318A2 Manipulation of cytokine levels using cd83 gene products
06/05/2003WO2003045317A2 Therapeutic protein and treatments
06/05/2003WO2003045316A2 Polynucleotide therapy
06/05/2003WO2003045128A2 SYNTHETIC IMMUNOGENIC BUT NON-DEPOSIT-FORMING POLYPEPTIDES AND PEPTIDES HOMOLOGOUS TO AMYLOID β, PRION PROTEIN, AMYLIN, α-SYNUCLEIN, OR POLYGLUTAMINE REPEATS FOR INDUCTION OF AN IMMUNE RESPONSE THERETO
06/05/2003WO2003010201A9 Blood group antigen fusion polypeptides and methods of use thereof
06/05/2003WO2003004526A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses and their use as medicines
06/05/2003WO2002102306A3 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy
06/05/2003WO2002083843A3 Outer membrane associated polypeptides
06/05/2003WO2002081665A3 Implantation serine proteinases
06/05/2003WO2002070542A3 Band 3 antigenic peptides, malaria polypeptides and uses thereof
06/05/2003WO2002062841A3 Secreted proteins
06/05/2003WO2002060932A3 A serpin in bifidobacteria
06/05/2003WO2002060485A3 Use of immunoregulatory antibodies in the treatment of neoplastic disorders
06/05/2003WO2002014478A3 IMMUNOGENIC HBc CHIMER PARTICLES HAVING ENHANCED STABILITY
06/05/2003US20030106084 Heat resistant antigen/cd24 fusion proteins; immunoglobulins; autoimmune disorders
06/05/2003US20030105318 G-protein transmembrane domain; protein synthesis inhibitor; neurotransmitter
06/05/2003US20030105307 Streptococcus pneumoniale 37-kDa surface adhesion a protein
06/05/2003US20030105304 Metal binding proteins and associated methods
06/05/2003US20030105282 Reduced binding affinity for cd4-antigen; immunoassays: vaccines
06/05/2003US20030105060 Synthetic oligomannosides, preparation and uses thereof
06/05/2003US20030105059 Regulation of human mast cell protease 6-like enzyme
06/05/2003US20030105054 For eliciting an immune response and enhancing current therapeutic modalities for the treatment of cancer; stimulates T cell proliferation
06/05/2003US20030105035 Administering synthetic, oligonucleotide, antibody that binds to epidermal growth factor receptor or a cytotoxic agent selected from taxanes, platinum-derived agents, and topoisomeraseII-selective drugs for inhibiting proliferation
06/05/2003US20030105003 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
06/05/2003US20030104998 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/05/2003US20030104622 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
1 ... 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 ... 1823